2023 Form 5500 filing — Biomarin Pharmaceutical Inc. Retirement Savings Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241011171830NAL0045269330001) for Biomarin Pharmaceutical Inc. Retirement Savings Plan, reported by Biomarin Pharmaceutical Inc. under EIN 68-0397820 and plan number 001. It reports 3,178 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241011171830NAL0045269330001
Filing year
2023
Form type
2
Plan sponsor
Biomarin Pharmaceutical Inc.
EIN
68-0397820
Plan number
001
Location
Novato, CA
Participants
3,178
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$616,847,325
Net assets (EOY)
$616,847,325
Employer contributions
$24,916,499
Participant contributions
$36,647,661
Total income / additions
$168,724,694
Benefits paid
$46,202,156
Administrative expenses
$50,285
Total expenses
$46,292,401
Net increase / (decrease)
$122,432,293
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Dynamic Wealth AdvisorsNONE$9,709not reported in the loaded dataset
Summitry LLCNONE$8,748not reported in the loaded dataset
Schwab Retirement Plan Services,IncNONE$6,900not reported in the loaded dataset
Creative Planning LLCNONE$6,533not reported in the loaded dataset
Abound Wealth Management LLCNONE$5,308not reported in the loaded dataset
Charles Schwab & Co., IncNONE$1,530$0

Related Form 5500 pages